Stemtech Corporation (STEK)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
At close: Jan 23, 2026

Stemtech Statistics

Total Valuation

Stemtech has a market cap or net worth of 297,266. The enterprise value is 4.17 million.

Market Cap297,266
Enterprise Value 4.17M

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

Stemtech has 495.44 million shares outstanding. The number of shares has increased by 29.44% in one year.

Current Share Class 495.44M
Shares Outstanding 495.44M
Shares Change (YoY) +29.44%
Shares Change (QoQ) +5.38%
Owned by Insiders (%) 7.78%
Owned by Institutions (%) 0.02%
Float 442.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.08
PB Ratio -0.05
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.41
EV / Sales 1.12
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio 0.10
Quick Ratio 0.06
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.32

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -30.63%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 27.68%
Weighted Average Cost of Capital (WACC) 21.92%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 80
Asset Turnover 1.01
Inventory Turnover 3.47

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.75% in the last 52 weeks. The beta is 2.26, so Stemtech's price volatility has been higher than the market average.

Beta (5Y) 2.26
52-Week Price Change -98.75%
50-Day Moving Average 0.00
200-Day Moving Average 0.02
Relative Strength Index (RSI) 32.48
Average Volume (20 Days) 14,336,342

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.00

Income Statement

In the last 12 months, Stemtech had revenue of 3.73 million and -2.96 million in losses. Loss per share was -0.02.

Revenue3.73M
Gross Profit 3.00M
Operating Income -1.81M
Pretax Income -2.96M
Net Income -2.96M
EBITDA -1.50M
EBIT -1.81M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 255,416 in cash and 4.87 million in debt, with a net cash position of -4.62 million or -0.01 per share.

Cash & Cash Equivalents 255,416
Total Debt 4.87M
Net Cash -4.62M
Net Cash Per Share -0.01
Equity (Book Value) -6.55M
Book Value Per Share -0.04
Working Capital -9.28M
Full Balance Sheet

Cash Flow

Operating Cash Flow -881,504
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 80.38%, with operating and profit margins of -48.55% and -79.34%.

Gross Margin 80.38%
Operating Margin -48.55%
Pretax Margin -79.43%
Profit Margin -79.34%
EBITDA Margin -40.23%
EBIT Margin -48.55%
FCF Margin n/a

Dividends & Yields

Stemtech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.44%
Shareholder Yield -29.44%
Earnings Yield -996.07%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Stemtech has an Altman Z-Score of -15.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.75
Piotroski F-Score 3